OBJECTIVETo investigate the suitability of intramuscular testosterone undecanoate (TU) injections for substitution therapy in hypogonadal men. STUDY DESIGNClinical, open-label, non-randomized trial of 13 hypogonadal men receiving 4 intramuscular injections of 1000 mg TU in 4-ml castor oil at 6-week intervals. General wellbeing, sexual parameters, clinical chemistry, hormone levels, prostate size and prostate-specific antigen (PSA) were evaluated over 24 weeks and compared with baseline values. RESULTSTestosterone serum levels were never found below the lower limit of normal and only briefly after the 3rd and 4th injection above the upper limit of normal, while peak and trough values increased over the 24-week observation period. Oestradiol and dihydrotestosterone followed this pattern, not exceeding the normal limits. No serious side-effects were noted. Slight increases in body weight, haemoglobin, haematocrit, prostate volume and PSA, suppression of gonadotrophins as well as increased ejaculation frequency occurred as signs of adequate testosterone substitution. CONCLUSIONTestosterone undecanoate is well tolerated by the patients. The injection intervals can be extended even beyond the 6-week periods chosen in the present study. Altogether, intramuscular testosterone undecanoate appears to be well suited for long-term substitution therapy in hypogonadism and hormonal male contraception.

Repeated intramuscolar injections of testosterone undecanoate for substitution therapy in hypogonadal men / Nieschlag, E; Büchter, D; VON ECKARDSTEIN, S; Abshagen, K; Simoni, Manuela; Behre, Hm. - In: CLINICAL ENDOCRINOLOGY. - ISSN 1059-0471. - ELETTRONICO. - 51:(1999), pp. 757-763.

Repeated intramuscolar injections of testosterone undecanoate for substitution therapy in hypogonadal men.

SIMONI, Manuela;
1999

Abstract

OBJECTIVETo investigate the suitability of intramuscular testosterone undecanoate (TU) injections for substitution therapy in hypogonadal men. STUDY DESIGNClinical, open-label, non-randomized trial of 13 hypogonadal men receiving 4 intramuscular injections of 1000 mg TU in 4-ml castor oil at 6-week intervals. General wellbeing, sexual parameters, clinical chemistry, hormone levels, prostate size and prostate-specific antigen (PSA) were evaluated over 24 weeks and compared with baseline values. RESULTSTestosterone serum levels were never found below the lower limit of normal and only briefly after the 3rd and 4th injection above the upper limit of normal, while peak and trough values increased over the 24-week observation period. Oestradiol and dihydrotestosterone followed this pattern, not exceeding the normal limits. No serious side-effects were noted. Slight increases in body weight, haemoglobin, haematocrit, prostate volume and PSA, suppression of gonadotrophins as well as increased ejaculation frequency occurred as signs of adequate testosterone substitution. CONCLUSIONTestosterone undecanoate is well tolerated by the patients. The injection intervals can be extended even beyond the 6-week periods chosen in the present study. Altogether, intramuscular testosterone undecanoate appears to be well suited for long-term substitution therapy in hypogonadism and hormonal male contraception.
1999
51
757
763
Repeated intramuscolar injections of testosterone undecanoate for substitution therapy in hypogonadal men / Nieschlag, E; Büchter, D; VON ECKARDSTEIN, S; Abshagen, K; Simoni, Manuela; Behre, Hm. - In: CLINICAL ENDOCRINOLOGY. - ISSN 1059-0471. - ELETTRONICO. - 51:(1999), pp. 757-763.
Nieschlag, E; Büchter, D; VON ECKARDSTEIN, S; Abshagen, K; Simoni, Manuela; Behre, Hm
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/607788
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 125
  • ???jsp.display-item.citation.isi??? 94
social impact